Lower medicine costs at higher pharmaceutical standards

Providing greater access to quality yet affordable health care has become a necessity to nations worldwide. Rising to the challenge in the pharmaceutical segment, Canadian company ACIC Group positions itself as a trusted partner that can help companies widen their reach and provide economical solutions to health care concerns.

"Many new drugs are more complicated to develop, and regulations are getting more stringent," says ACIC president Luciano Calenti. "If we want to support health care systems around the world, we need drugs that are more competitive than those currently available on the market. Asia has the potential to supply a big portion."

Initially providing active pharmaceutical ingredients (APIs) and antibiotics to the United States and Canadian markets, ACIC has expanded its portfolio to provide

a full spectrum of services across four divisions: fine chemicals, pharmaceuticals, biosimilars and machinery. Operating for more than 40 years, ACIC lends its extensive expertise to pharmaceutical suppliers in order to help increase their standards in the quality manufacturing of industry-compliant products.

The company acts as a bridge linking suppliers and end-product manufacturers. Sharing its knowledge on the fastest and most efficient way to enable companies to take their products to market, ACIC provides partners with APIs, contract manufacturing services, process development and optimisation, clinical services, and finished dosage forms from facilities approved by Current Good Manufacturing Practices (CGMP) and inspected by the Food and Drug Administration (FDA).

Renowned in the industry for its commitment to health care, ACIC was recognised at the 2012 Contract Manufacturing Organization (CMO) Leadership Awards in the categories of innovation, productivity and regulatory. Only companies in the top 25th percentile of more than 200 CMOs worldwide were selected to receive awards.

Adopting a global development approach, ACIC is partnering with companies from around the world. "We are not a multinational company, but we think and act like a multinational company through our strategic alliances," Calenti says.